期刊文献+

灵芪胶囊含药血清对人红白血病K562细胞增殖抑制作用的影响 被引量:2

Effects of the Herb Serum Containing LQC on the Proliferation of K562 Leukemia Cells
暂未订购
导出
摘要 目的:观察灵芪胶囊(LQC)含药血清在体外对K562白血病细胞增殖抑制作用的影响。方法:采用血清药理学方法制备灵芪胶囊含药血清,以不同浓度的含药血清处理体外培养的K562白血病细胞,并测定抑制率、分裂指数以及克隆形成能力,观察灵芪胶囊含药血清对肿瘤细胞的抑制作用;用W right-G iemsa染色方法观察肿瘤细胞形态的变化。结果:不同浓度灵芪胶囊含药血清对K562细胞的增殖具有抑制作用,并呈剂量依赖关系;灵芪胶囊含药血清对肿瘤细胞的分裂指数和克隆形成能力均具有显著的降低作用,在一定的时间内与剂量呈正相关,同时亦使肿瘤细胞的形态结构发生改变。结论:灵芪胶囊含药血清对K562白血病细胞具有细胞毒作用,其直接杀伤和破坏肿瘤细胞的作用是灵芪胶囊抗肿瘤的主要机理之一。 Objective: To study the effect of the herb serum containing LQC on the proliferation of K562 leukemia cells in vitro.Methods: Prepared the herb serum containing LQC with serum-pharmacology method and treated the K562 leukemia cells with contained herb serum of LQC in different concentration.The inhibitive and morphological effect of LQC on tumor cell with cell culture in vitro were observed by detecting the inhibitory rate,divisional index,clonality and Wright-Giemsa stain.Results: The herb serum containing LQC in different concentration could inhibit the proliferation of K562 leukemia cells directly and showed the dose-dependent.And LQC exhibited the inhibitory action on divisional index and clonality of tumor cells.LQC also could change the morphological structure of K562 cells.Conclusion: The herb serum containing LQC had cytotoxic action on K562 leukemia cells,and the action of lethal and breakdown effect directly on tumor cells was one of the main anti-tumor mechanisms of LQC.
出处 《中医药信息》 2009年第1期83-86,共4页 Information on Traditional Chinese Medicine
基金 黑龙江中医药大学重大基金(200503)
关键词 灵芪胶囊 血清药理学 K562细胞系 分裂指数 Ling-Qi capsule Serum-pharmacology K562 cell line Divisional index
  • 相关文献

参考文献5

二级参考文献31

共引文献135

同被引文献13

  • 1古翠萍,张沂平.TNF-α抗肿瘤作用机制新进展[J].中国肿瘤,2007,16(2):102-105. 被引量:43
  • 2Youssef I. Antimutagenie Effect of Fruit and Vegetable Ethanolic Extracts against-N-Nitrosamines Evaluated by the Ames Test [ J ]. Agric Food Chem, 1999,47 ( 8 ) :3257
  • 3Godwin J.Design and conduct of a double-blind, placebocontrolled trial of daunorubicin and cytarabine with or withoutgranulocyte colong-stimulating factor in elderly patients with acute myeloid leukemia:a southwest oncology group study[J].J Natl Cancer Inst Monogy, 1995(19):31-35.
  • 4Copplestone JA, Smith AG. Acute myeloid leukemia: in the elderly[J].Leuk Res,1988,12:617-625.
  • 5Stone RM. The difficult problem of acute myeloid leukemia in the older adult[J].CA Cancer J Clin, 2002,52(6):363-371.
  • 6Yamada K, Furusawa S, Saito K, et al.Coocurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia:a pilot study[J]. Leukamia,1995,9(1):10-14.
  • 7Saito K,Nakamura Y,hoyagi M, et al. Low-dose cytarabine and aclarubicin in combination with granulo- cyte colony-stimulating factor(CAG regimen)for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML)and previously untreated elderly patients with AML secondary AML. and refractory anemia with excese blasts in transformation[J].Int 3 Hematol,2000,71(3):238-244.
  • 8Bai h, Kojima H,Hori M,et al. Priming with G-CSF effectively enhances low-dose Arac-cinduced in vivo apotosis in myeloid leukemia cells[J].Exp aematol, 1999,27(2):259-265.
  • 9苏云明,刘莉,孟繁兴,王欣,刘春华.灵芪胶囊含药血清对K562白血病细胞影响[J].哈尔滨商业大学学报(自然科学版),2007,23(5):517-519. 被引量:2
  • 10上海市白血病协作组.上海地区老年急性白血病417例回顾性研究[J].中华血液学杂志,1998,19(1):3-5. 被引量:83

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部